RT Journal Article
T1 104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain.
A1 Pereyra-Rodriguez, Jose Juan
A1 Dominguez-Cruz, Javier
A1 Armario-Hita, Jose Carlos
A1 Ruiz-Villaverde, Ricardo
YR 2021
FD 2021-09-27
LK https://hdl.handle.net/10668/25495
UL https://hdl.handle.net/10668/25495
LA en
DS RISalud
RD Apr 8, 2025